SE0004840718
SE0004840718
Xvivo Perfusion AB
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 812.165.000 | 822.415.000 | 1.2% |
| Cost of Revenue | 212.673.000 | 206.000.000 | 3.2% |
| Gross Profit | 599.492.000 | 616.415.000 | 2.7% |
| 507.370.000 | 527.009.000 | 3.7% | |
| Operating Income | 92.122.000 | 89.406.000 | 3.0% |
| Pretax Income | 38.561.000 | 199.948.000 | 80.7% |
| Net Income Common Stockholders | 25.163.000 | 172.182.000 | 85.4% |
| -- | -- | -- | |
| -- | -- | -- |